Review of therapeutic agents for the treatment of COVID-19

Review of therapeutic agents for the treatment of COVID-19

Shadi Ziaie, Sara Salarian, Mehrdad Haghighi, Mirmohammad Miri, Mohammad Sistanizad, Seyedpouzhia Shojaei, Mehran Koucheck

In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China, named coronavirus disease 2019 (COVID -19) which has been spreading in 204 countries. In this review, the mains pharmaceutical option quoted previously and especially available for ICU patients are reviewed.

2020

immunomodulators, antiviral, Pharmacotherapy, COVID-19

DOI: 10.22037/jcma.v5i1.29760

Journal of Cellular and Molecular Anesthesia

Shahid Beheshti University of Medical Sciences

Anesthesiology